Study of BDTX-1535 in Recurrent High-Grade Glioma (HGG) Participants With EGFR Alterations or Fusions
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06072586 |
|
Recruitment Status :
Recruiting
First Posted : October 10, 2023
Last Update Posted : November 28, 2023
|
Sponsor:
St. Joseph's Hospital and Medical Center, Phoenix
Collaborators:
Ivy Brain Tumor Center
Barrow Neurological Institute
Information provided by (Responsible Party):
St. Joseph's Hospital and Medical Center, Phoenix
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2025 |
| Estimated Study Completion Date : | October 31, 2025 |